$0.6300
0.011.61%
At close: -
$0.6298
-0.00020-0.03%
After Hours: Dec 19, 9:03 AM EDT
Cyclo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cyclo Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.31 | $-0.16 | -93.8 % |
Jun 2024 | 2024-08-14 | $-0.21 | $-0.15 | -40.0 % |
Jun 2023 | 2023-08-14 | $-0.33 | $-0.44 | 25.0 % |
Mar 2023 | 2023-05-15 | $-0.46 | $-0.42 | -9.52 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $233.77K | $294.00K | -20.5 % |
Jun 2024 | 2024-08-14 | $123.10K | $270.00K | -54.4 % |
Sep 2023 | 2023-11-14 | $459.48K | $430.00K | 6.86 % |
Jun 2023 | 2023-08-14 | $117.12K | $400.00K | -70.7 % |
Cyclo Therapeutics (CYTH) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.31, which missed the estimate of $-0.16.
The Actual Revenue was $233.8K, which missed the estimate of $294K.
Browse earnings estimates, EPS, and revenue on all stocks.